钠-葡萄糖协同转运蛋白2抑制剂的影响：心力衰竭及其他方面。 - Suppr

Suppr

超能文献

The impact of SGLT 2 inhibitors: Heart failure and beyond.

作者信息

Mansoor Misha, Shafiq Muhammad Hamza, Khalique Faisal

机构信息

Allama Iqbal Medical College, 164-C Faisal Town, Lahore, 54700, Pakistan.

Lahore Medical and Dental College, Lahore, Pakistan.

出版信息

Ir J Med Sci. 2024 Aug;193(4):1773-1774. doi: 10.1007/s11845-024-03644-2. Epub 2024 Feb 28.

DOI:10.1007/s11845-024-03644-2

PMID:38416375

Abstract

摘要

相似文献

The impact of SGLT 2 inhibitors: Heart failure and beyond.钠-葡萄糖协同转运蛋白2抑制剂的影响：心力衰竭及其他方面。

Ir J Med Sci. 2024 Aug;193(4):1773-1774. doi: 10.1007/s11845-024-03644-2. Epub 2024 Feb 28.

SGLT-2 Inhibitors in Heart Failure and Type-2 Diabetes: Hitting Two Birds with One Stone?钠-葡萄糖协同转运蛋白2抑制剂用于心力衰竭和2型糖尿病：一石二鸟？

Cardiology. 2020;145(5):311-320. doi: 10.1159/000504694. Epub 2019 Dec 20.

Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis.在基层医疗中为 2 型糖尿病开具钠-葡萄糖共转运蛋白 2 抑制剂：肾功能和心力衰竭诊断的影响。

Cardiovasc Diabetol. 2021 Jun 28;20(1):130. doi: 10.1186/s12933-021-01316-4.

Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study.钠-葡萄糖共转运蛋白 2 抑制剂与 2 型糖尿病患者心力衰竭风险降低的相关性：一项真实世界的全国范围内基于人群的队列研究。

Cardiovasc Diabetol. 2018 Jun 23;17(1):91. doi: 10.1186/s12933-018-0737-5.

Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.钠-葡萄糖共转运蛋白 2 抑制剂在心力衰竭预防和治疗中的临床应用：超越 2 型糖尿病。一篇叙述性综述。

Adv Ther. 2022 Feb;39(2):845-861. doi: 10.1007/s12325-021-01989-z. Epub 2021 Dec 9.

Current Perspectives of the Use of Sodium-Glucose Transport-2 Inhibitors for Patients With Heart Failure and Chronic Kidney Disease.钠-葡萄糖协同转运蛋白2抑制剂用于心力衰竭和慢性肾脏病患者的当前观点

J Cardiovasc Pharmacol. 2022 Mar 1;79(3):247-253. doi: 10.1097/FJC.0000000000001176.

Sodium-glucose co-transporter 2 inhibitors and heart failure-the present and the future.钠-葡萄糖共转运蛋白 2 抑制剂与心力衰竭：现状与未来。

Heart Fail Rev. 2021 Jul;26(4):953-960. doi: 10.1007/s10741-020-09925-z.

Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis.新型降糖药物对 2 型糖尿病患者心力衰竭风险的比较：网络荟萃分析。

JACC Heart Fail. 2018 Oct;6(10):823-830. doi: 10.1016/j.jchf.2018.05.021. Epub 2018 Sep 5.

[«Diabetes Drugs» without Diabetes: SGLT-2 Inhibitors].

Praxis (Bern 1994). 2023 Aug;112(10):500-506.

SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives.钠-葡萄糖协同转运蛋白 2（SGLT-2）抑制剂在心力衰竭中的应用：处方指导与未来展望。

Curr Cardiol Rep. 2021 May 7;23(6):59. doi: 10.1007/s11886-021-01486-3.

本文引用的文献

Effect of Dapagliflozin on Patients with Rheumatic Heart Disease Mitral Stenosis.达格列净对风湿性心脏病二尖瓣狭窄患者的影响。

J Clin Med. 2023 Sep 11;12(18):5898. doi: 10.3390/jcm12185898.

The Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Anthracycline-Treated Patients With Cancer.蒽环类药物治疗的癌症患者中，钠-葡萄糖协同转运蛋白2抑制剂与心血管结局的关联。

JACC CardioOncol. 2023 May 2;5(3):318-328. doi: 10.1016/j.jaccao.2023.03.011. eCollection 2023 Jun.

Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.达格列净对DAPA-HF研究中室性心律失常、心脏复苏后骤停或心源性猝死的影响。

Eur Heart J. 2021 Sep 21;42(36):3727-3738. doi: 10.1093/eurheartj/ehab560.

Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials.SGLT2 抑制剂与 2 型糖尿病或心力衰竭患者心律失常和心源性猝死的关系：34 项随机对照试验的荟萃分析。

Heart Rhythm. 2021 Jul;18(7):1098-1105. doi: 10.1016/j.hrthm.2021.03.028. Epub 2021 Mar 20.

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.恩格列净治疗心力衰竭的心血管和肾脏结局。

N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28.

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者。

N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.

Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC).英国初级医疗中心血管疾病的发病率和患病率：皇家全科医师学院（RCGP）研究与监测中心（RSC）的一项横断面和随访研究。

BMJ Open. 2018 Aug 20;8(8):e020282. doi: 10.1136/bmjopen-2017-020282.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验